NM

Nuala Moran

crewe, england, united kingdom

Publications:

Featured Articles

MHRA joins EMA in taking Amgen's Tavneos off the market | BioWorld

BioWorld BioWorld Science BioWorld Asia Special reports Infographics: Dynamic digital data analysis BCI Ebola outbreak Hantavirus Trump administration impacts Med-tech outlook 2026 Under threat: mRNA vaccine research BioWorld at 35 Biopharma M&A score... See more

bioworld.com•Nuala Moran•Sep 2, 2026

EMA pilot on new methodologies that could replace animal tests | BioWorld

BioWorld BioWorld Science BioWorld Asia Special reports Infographics: Dynamic digital data analysis BCI Ebola outbreak Hantavirus Trump administration impacts Med-tech outlook 2026 Under threat: mRNA vaccine research BioWorld at 35 Biopharma M&A score... See more

bioworld.com•Nuala Moran•Sep 2, 2026

European regulators recall Amgen's rare disease drug Tavneos | BioWorld

BioWorld BioWorld Science BioWorld Asia Special reports Infographics: Dynamic digital data analysis BCI Ebola outbreak Hantavirus Trump administration impacts Med-tech outlook 2026 Under threat: mRNA vaccine research BioWorld at 35 Biopharma M&A score... See more

bioworld.com•Nuala Moran•Aug 21, 2026

Leo Pharma seals $450M deal with Tanabe for rare skin disease drug | BioWorld

BioWorld BioWorld Science BioWorld Asia Special reports Infographics: Dynamic digital data analysis BCI Ebola outbreak Hantavirus Trump administration impacts Med-tech outlook 2026 Under threat: mRNA vaccine research BioWorld at 35 Biopharma M&A score... See more

bioworld.com•Nuala Moran•Aug 18, 2026

Redx to join Nasdaq via Skye merger; raises $125M privately | BioWorld

BioWorld BioWorld Science BioWorld Asia Special reports Infographics: Dynamic digital data analysis BCI Ebola outbreak Hantavirus Trump administration impacts Med-tech outlook 2026 Under threat: mRNA vaccine research BioWorld at 35 Biopharma M&A score... See more

bioworld.com•Nuala Moran•Aug 17, 2026

Bylined Articles

HARO Queries

Nuala Moran

Is this you?

Featured Articles

MHRA joins EMA in taking Amgen's Tavneos off the market | BioWorld

EMA pilot on new methodologies that could replace animal tests | BioWorld

European regulators recall Amgen's rare disease drug Tavneos | BioWorld

Leo Pharma seals $450M deal with Tanabe for rare skin disease drug | BioWorld

Redx to join Nasdaq via Skye merger; raises $125M privately | BioWorld

Is this you?

Social Media

Connect with journalists.

Connect with journalists.

Featured Articles

MHRA joins EMA in taking Amgen's Tavneos off the market | BioWorld

EMA pilot on new methodologies that could replace animal tests | BioWorld

European regulators recall Amgen's rare disease drug Tavneos | BioWorld

Leo Pharma seals $450M deal with Tanabe for rare skin disease drug | BioWorld

Redx to join Nasdaq via Skye merger; raises $125M privately | BioWorld

Social Media